Abraxane: Breast Cancer Drug Approved By FDA To Treat Lung Cancer
Celgene, whose shares rose as much as 2.6 percent Friday morning, acquired Abraxane when it bought Abraxis BioScience in
abraxane breast cancer drug approve fda treat lung cancer celgene share rise percent friday morning acquire abraxane buy abraxis bioscience